High-dose Vitamin D3 in adults with pulmonary tuberculosis: A double-blind randomized controlled trial

American Journal of Clinical Nutrition

Volumn 102, Issue 5, 2015, Pages 1059-1069

  Tukvadze, Nestan ^a   Sanikidze, Ekaterina ^a   Kipiani, Maia ^a   Hebbar, Gautam ^b   Easley, Kirk A ^c   Shenvi, Neeta ^c   Kempker, Russell R ^b   Frediani, Jennifer K ^b   Mirtskhulava, Veriko ^a,b   Alvarez, Jessica A ^b   Lomtadze, Nino ^a   Vashakidze, Lamara ^a   Hao, Li ^b   Del Rio, Carlos ^b,c   Tangpricha, Vin ^b,d   Blumberg, Henry M ^b,c   Ziegler, Thomas R ^b  

^a National Center for Tuberculosis and Lung Diseases   (Georgia)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Multidrug resistant tuberculosis; Mycobacterium tuberculosis; Randomized controlled trial; Tuberculosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; ETHAMBUTOL; ISONIAZID; PLACEBO; PYRAZINAMIDE; RIFAMPICIN; VITAMIN D RECEPTOR; CALCIFEDIOL; TUBERCULOSTATIC AGENT;

ADD ON THERAPY; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CLEARANCE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; DIRECTLY OBSERVED THERAPY; DOUBLE BLIND PROCEDURE; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GENETIC POLYMORPHISM; HUMAN; HYPERCALCEMIA; INTENTION TO TREAT ANALYSIS; LUNG CARCINOMA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NEPHROLITHIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SPUTUM CULTURE; SPUTUM SMEAR; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ADOLESCENT; ADVERSE EFFECTS; BLOOD; COHORT ANALYSIS; COMPLICATION; DIET THERAPY; DIETARY SUPPLEMENT; DRUG EFFECTS; GEORGIA (REPUBLIC); IMMUNOLOGY; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATIENT DROPOUT; SPUTUM; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; CALCIFEDIOL; CHOLECALCIFEROL; COHORT STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GEORGIA (REPUBLIC); HUMANS; INTENTION TO TREAT ANALYSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PATIENT DROPOUTS; SPUTUM; TUBERCULOSIS, PULMONARY; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84946087022     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.113886     Document Type: Article

References (31)

1. World Health Organization. WHO global report. Geneva (Switzerland): WHO Global TB Programme; 2014.
2. Dheda K, Gumbo T, Gandhi NR, Murray M, Theron G, Udwadia Z, Migliori GB, Warren R. Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. Lancet Respir Med 2014;2:321-38.
3. Lomtadze N, Aspindzelashvili R, Janjgava M, Mirtskhulava V, Wright A, Blumberg HM, Salakaia A. Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a populationbased study. Int J Tuberc Lung Dis 2009;13:68-73.
4. Kempker RR, Rabin AS, Nikolaishvili K, Kalandadze I, Gogishvili S, Blumberg HM, Vashakidze S. Additional drug resistance in Mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosis. Clin Infect Dis 2012;54:e51-4.
5. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, et al. Toll-like receptor triggering of a Vitamin D-mediated human antimicrobial response. Science 2006;311:1770-3.
6. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
7. Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, Hall BM, Packe GE, Davidson RN, Eldridge SM, Maunsell ZJ, et al. A single dose of Vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007;176:208-13.
8. Miller J, Gallo RL. Vitamin D and innate immunity. Dermatol Ther 2010;23:13-22.
9. Fabri M, Stenger S, Shin DM, Yuk JM, Liu PT, Realegeno S, Lee HM, Krutzik SR, Schenk M, Sieling PA, et al. Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med 2011;3:104ra102.
10. Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, Timms PM, Venton TR, Bothamley GH, Packe GE, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci USA 2012;109:15449-54.
11. Wejse C, Olesen R, Rabna P, Kaestel P, Gustafson P, Aaby P, Andersen PL, Glerup H, Sodemann M. Serum 25-hydroxyVitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am J Clin Nutr 2007;86:1376-83.
12. Yamshchikov AV, Kurbatova EV, Kumari M, Blumberg HM, Ziegler TR, Ray SM, Tangpricha V. Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am J Clin Nutr 2010;92:603-11.
13. Martineau AR, Nhamoyebonde S, Oni T, Rangaka MX, Marais S, Bangani N, Tsekela R, Bashe L, de Azevedo V, Caldwell J, et al. Reciprocal seasonal variation in Vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci USA 2011;108:19013-7.
14. Desai NS, Tukvadze N, Frediani JK, Kipiani M, Sanikidze E, Nichols MM, Hebbar G, Kempker RR, Mirtskhulava V, Kalandadze I, et al. Effects of sunlight and diet on Vitamin D status of pulmonary tuberculosis patients in Tbilisi, Georgia. Nutrition 2012;28:362-6.
15. Kim JH, Park JS, Cho YJ, Yoon HI, Song JH, Lee CT, Lee JH. Low serum 25-hydroxyVitamin D level: an independent risk factor for tuberculosis? Clin Nutr 2014;33:1081-6.
16. Mehta S, Mugusi FM, Bosch RJ, Aboud S, Urassa W, Villamor E, Fawzi WW. Vitamin D status and TB treatment outcomes in adult patients in Tanzania: a cohort study. BMJ Open 2013;3:e003703.
17. Nursyam EW, Amin Z, Rumende CM. The effect of Vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006;38:3-5.
18. Wejse C, Gomes VF, Rabna P, Gustafson P, Aaby P, Lisse IM, Andersen PL, Glerup H, Sodemann M. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009;179:843-50.
19. Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, Packe GE, Moore-Gillon JC, Darmalingam M, Davidson RN, et al. High-dose Vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011;377:242-50.
20. Kota SK, Jammula S, Kota SK, Tripathy PR, Panda S, Modi KD. Effect of Vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes Metab Syndr 2011;5:85-9.
21. Ralph AP, Waramori G, Pontororing GJ, Kenangalem E, Wiguna A, Tjitra E, Sandjaja, Lolong DB, Yeo TW, Chatfield MD, et al. L-arginine and Vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial. PLoS One 2013;8:e70032.
22. Salahuddin N, Ali F, Hasan Z, Rao N, Aqeel M, Mahmood F. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of Vitamin D supplementation in patients with pulmonary tuberculosis. BMC Infect Dis 2013;13:22.
23. Daley P, Jagannathan V, John KR, Sarojini J, Latha A, Vieth R, Suzana S, Jeyaseelan L, Christopher DJ, Smieja M, et al. Adjunctive Vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2015;15:528-34.
24. Tukvadze N, Kempker RR, Kalandadze I, Kurbatova E, Leonard MK, Apsindzelashvili R, Bablishvili N, Kipiani M, Blumberg HM. Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis. PLoS One 2012;7:e31563.
25. Tukvadze N, Bablishvili N, Apsindzelashvili R, Blumberg HM, Kempker RR. Performance of the MTBDRsl assay in Georgia. Int J Tuberc Lung Dis 2014;18:233-9.
26. Pepper KJ, Judd SE, Nanes MS, Tangpricha V. Evaluation of Vitamin D repletion regimens to correct Vitamin D status in adults. Endocr Pract 2009;15:95-103.
27. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, et al. The 2011 report on dietary reference intakes for calcium and Vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53-8.
28. Frediani JK, Tukvadze N, Sanikidze E, Kipiani M, Hebbar G, Easley KA, Shenvi N, Ramakrishnan U, Tangpricha V, Blumberg HM, et al. A culture-specific nutrient intake assessment instrument in patients with pulmonary tuberculosis. Clin Nutr 2013;32:1023-8.
29. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine-reporting of subgroup analyses in clinical trials. N Engl J Med 2007;357:2189-94.
30. Azad AK, Sadee W, Schlesinger LS. Innate immune gene polymorphisms in tuberculosis. Infect Immun 2012;80:3343-59.
31. Karim F, Ahmed F, Begum I, Johansson E, Diwan VK. Femalemale differences at various clinical steps of tuberculosis management in rural Bangladesh. Int J Tuberc Lung Dis 2008;12: 1336-9.